SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Dreesen Erwin)
 

Search: WFRF:(Dreesen Erwin) > Bosentan Alters End...

Bosentan Alters Endo- and Exogenous Bile Salt Disposition in Sandwich-Cultured Human Hepatocytes

Oorts, Marlies (author)
Katholieke Univ Leuven, Drug Delivery & Disposit, Leuven, Belgium.
Van Brantegem, Pieter (author)
Katholieke Univ Leuven, Drug Delivery & Disposit, Leuven, Belgium.
Deferm, Neel (author)
Katholieke Univ Leuven, Drug Delivery & Disposit, Leuven, Belgium.
show more...
Chatterjee, Sagnik (author)
Syngene Int, Biocon Bristol Myers Squibb Res Ctr, Pharmaceut Candidate Optimizat, Bangalore, Karnataka, India.
Dreesen, Erwin (author)
Uppsala universitet,Institutionen för farmaci,Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy, Leuven, Belgium.
Cooreman, Axelle (author)
Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium.
Vinken, Mathieu (author)
Vrije Univ Brussel, Dept Pharmaceut & Pharmacol Sci, Brussels, Belgium.
Richert, Lysiane (author)
KaLy Cell, Plobsheim, France.
Annaert, Pieter (author)
Katholieke Univ Leuven, Drug Delivery & Disposit, Leuven, Belgium.;BioNotus, Niel, Belgium.
show less...
Katholieke Univ Leuven, Drug Delivery & Disposit, Leuven, Belgium Syngene Int, Biocon Bristol Myers Squibb Res Ctr, Pharmaceut Candidate Optimizat, Bangalore, Karnataka, India. (creator_code:org_t)
2021-08-04
2021
English.
In: Journal of Pharmacology and Experimental Therapeutics. - : American Society for Pharmacology & Experimental Therapeutics (ASPET). - 0022-3565 .- 1521-0103. ; 379:1, s. 20-32
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Bosentan, a well-known cholestatic agent, was not identified as cholestatic at concentrations up to 200 mM based on the drug-induced cholestasis (DIC) index value, determined in a sandwich-cultured human hepatocyte (SCHH)-based DIC assay. To obtain further quantitative insights into the effects of bosentan on cellular bile salt handling by human hepatocytes, the present study determined the effect of 2.5-25 mu M bosentan on endogenous bile salt levels and on the disposition of 10 mu M chenodeoxycholic acid (CDCA) added to the medium in SCHHs. Bosentan reduced intracellular as well as extracellular concentrations of both endogenous glycochenodeoxycholic acid (GCDCA) and glycocholic acid in a concentration-dependent manner. When exposed to 10 mu M CDCA, bosentan caused a shift from canalicular efflux to sinusoidal efflux of GCDCA. CDCA levels were not affected. Our mechanistic model confirmed the inhibitory effect of bosentan on canalicular GCDCA clearance. Moreover, our results in SCHHs also indicated reduced GCDCA formation. We confirmed the direct inhibitory effect of bosentan on CDCA conjugation with glycine in incubations with liver S9 fraction.SIGNIFICANCE STATEMENT Bosentan was evaluated at therapeutically relevant concentrations (2.5-25 mu M) in sandwich-cultured human hepatocytes. It altered bile salt disposition and inhibited canalicular secretion of glycochenodeoxycholic acid (GCDCA). Within 24 hours, bosentan caused a shift from canalicular to sinusoidal efflux of GCDCA. These results also indicated reduced GCDCA formation. This study confirmed a direct effect of bosentan on chenodeoxycholic acid conjugation with glycine in liver S9 fraction.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view